Italia markets close in 1 hour 54 minutes

ILMN Jan 2025 85.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
4,90000,0000 (0,00%)
In data: 01:54PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente4,9000
Aperto5,1300
Denaro0,0000
Lettera0,0000
Prezzo d'esercizio85,00
Scadenza2025-01-17
Min-Max giorno4,9000 - 5,1300
Contratto - Min-MaxN/D
Volume1
Open Interest184
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera